Nancy Reilly Ellen Tedaldi. Barry Schmetter Robert Vallier. CPCRA 058 (FIRST) team ... Grace Peng. Li Chen. Ying Xiang. CPCRA Operations Center. Caron Lee ...
Workgroup for the Biopharmaceutical Section of the American Statistical Association ... Conservative (but not for equivalence studies) CPCRA Oral Ganciclovir Study ...
1. C P C R A. 2. C P C R A. SMART Study Design. Drug Conservation (DC) Strategy ... Results of SMART are relevant to the expansion of ART in resource limited countries ...
The Cafeteria Test Good policy and a good research protocol can be explained to your surgeon colleague in the noisy hospital cafeteria, between two beepers ...
H-1027 Prediction of disease progression by HIV co-receptor tropism (CRT) in persons (P) with untreated chronic HIV infection Matthew B. Goetz1 , Robert Leduc2, Jay R ...
African American race. Social/environmental: Lack of insurance or access. Active substance use ... independent of education and drug use history in some studies ...
... 3. Wayne State University, Detroit, Mi, USA 4. University of Illinois, ... (age, race, gender, prior AIDS, history of injection drug use, baseline CD4 ...
J rgen Rockstroh, Department of Medicine I, ... Likelihood of developing AIDS by 3 years after becoming infected with HIV-1 ... EFV: teratogenic in 1st trimester ...
New HIV Therapy Anton Pozniak Chelsea and Westminster Hospital London UK What Nucleosides? Gilead 903: 96 Week Virologic Response Gilead 903: Fasting Lipid Profile at ...
Response to NNRTI-HAART in women who received SD-NVP (MTCT) ... higher' - FC at which response is essentially gone (80% in response) Step 4: Validation ...
... recently, spurred on by the unexpected synergism of 3TC when used in combo with ... Viramune® has shown some synergism (enhanced effect) when used in ...
... Support as well as the ACPE Criteria for Quality and ... Cohort study. 472 HIV patients followed for 8343 patient-months. HIV alone (n=126) HIV/HBV (n=72) ...
US government sponsored HIV prevention research is in a time of flux ... Source: http://grants1.nih.gove/grants/guide/rfa-files/RFA-AI-05-001.html 'Old' DAIDS Networks ...
CROI 2004 - K.L White, Foster City, abstract 55, actualis ... J. Mellors, Pittsburgh, abstract 39, actualis . Pr trait s par INNTI avec mutation de ...
Capital Technology Information Services, Inc. Disease Management Informatics Architecture Framework Presented to Disease Management Challenges Disease Management ...
Prevalence of resistance mutations in a cohort of treatment-na ve people with ... Berg-Wolf7, M Kozal8 and the CPCRA 058 Study Team for the Terry Beirn Community ...